CD8A and cancer: In the context of cancer and chronic infection, CD8+ T cells may undergo exhaustion or dysfunction, marked by the upregulation of immune checkpoints like PD-1(PDCD1), CTLA4, LAG3, TIGIT, and TIM3(HAVCR2), impairing their anti-tumoral function (12, 13).